Topical Skin Formulations Of A Pharmaceutically Acceptable Salt Of Ruxolitinib
PH12026550016A1Pending Publication Date: 2026-08-17INCYTE CORP
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12026550016
- Authority / Receiving Office
- PH · PH
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-01-06
- Publication Date
- 2026-08-17
Need to check novelty before this filing date? Find Prior Art
No text content released.